Preoperative serum albumin levels predict 1-year postoperative survival of patients undergoing heart transplantation

Circulation: Heart Failure

Volumn 6, Issue 4, 2013, Pages 785-791

  Kato, Tomoko S ^a   Cheema, Faisal H ^a   Yang, Jonathan ^a   Kawano, Yumeko ^a   Takayama, Hiroo ^a   Naka, Yoshifumi ^a   Farr, Maryjane ^a   Lederer, David J ^a,b   Baldwin, Matthew R ^a   Jin, Zhezhen ^a,b   Homma, Shunichi ^a   Mancini, Donna M ^a   Schulze, P Christian ^a  

^a Department of Medicine   (United States)

^b Department of Medicine   (United States)

Author keywords

Albumin; Heart transplantation; Prognosis

Indexed keywords

BILIRUBIN; SERUM ALBUMIN; ALBUMIN;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; FEMALE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMAN; HYPOALBUMINEMIA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SURGICAL MORTALITY; SURGICAL PATIENT; SURVIVAL PREDICTION; SURVIVAL RATE; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PREOPERATIVE PERIOD; PROGNOSIS;

ALBUMIN; HEART TRANSPLANTATION; PROGNOSIS;

ADULT; FEMALE; HEART TRANSPLANTATION; HUMANS; HYPOALBUMINEMIA; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREOPERATIVE PERIOD; PROGNOSIS; SERUM ALBUMIN;

EID: 84884708893     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.111.000358     Document Type: Article

References (32)

1. Don BR, Kaysen G. Serum albumin: relationship to inflammation and nutrition. Semin Dial. 2004;17:432-437.
2. Fuhrman MP, Charney P, Mueller CM. Hepatic proteins and nutrition assessment. J Am Diet Assoc. 2004;104:1258-1264.
3. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340:448-454.
4. Kaysen GA, Dubin JA, Müller HG, Rosales L, Levin NW, Mitch WE; HEMO Study Group NIDDK. Inflammation and reduced albumin synthesis associated with stable decline in serum albumin in hemodialysis patients. Kidney Int. 2004;65:1408-1415.
5. Ramsey S, Lamb GW, Aitchison M, Graham J, McMillan DC. Evaluation of an inflammation-based prognostic score in patients with metastatic renal cancer. Cancer. 2007;109:205-212.
6. Horwich TB, Kalantar-Zadeh K, MacLellan RW, Fonarow GC. Albumin levels predict survival in patients with systolic heart failure. Am Heart J. 2008;155:883-889.
7. Uthamalingam S, Kandala J, Daley M, Patvardhan E, Capodilupo R, Moore SA, Januzzi JL Jr. Serum albumin and mortality in acutely decompensated heart failure. Am Heart J. 2010;160:1149-1155.
8. de la Cruz KI, Bakaeen FG, Wang XL, Huh J, LeMaire SA, Coselli JS, Chu D. Hypoalbuminemia and long-term survival after coronary artery bypass: a propensity score analysis. Ann Thorac Surg. 2011; 91:671-6.
9. Engelman DT, Adams DH, Byrne JG, Aranki SF, Collins JJ Jr, Couper GS, Allred EN, Cohn LH, Rizzo RJ. Impact of body mass index and albumin on morbidity and mortality after cardiac surgery. J Thorac Cardiovasc Surg. 1999;118:866-873.
10. Gibbs J, Cull W, Henderson W, Daley J, Hur K, Khuri SF. Preoperative serum albumin level as a predictor of operative mortality and morbidity: results from the National VA Surgical Risk Study. Arch Surg. 1999;134:36-42.
11. Zimmerman JE, Kramer AA, McNair DS, Malila FM. Acute Physiology and Chronic Health Evaluation (APACHE) IV: hospital mortality assessment for today's critically ill patients. Crit Care Med. 2006;34:1297-1310.
12. Stehlik J, Edwards LB, Kucheryavaya AY, Benden C, Christie JD, Dobbels F, Kirk R, Rahmel AO, Hertz MI. The Registry of the International Society for Heart and Lung Transplantation: Twentyeighth Adult Heart Transplant Report-2011. J Heart Lung Transplant. 2011;30:1078-1094.
13. Jaski BE, Kim JC, Naftel DC, Jarcho J, Costanzo MR, Eisen HJ, Kirklin JK, Bourge RC; Cardiac Transplant Research Database Research Group. Cardiac transplant outcome of patients supported on left ventricular assist device vs. intravenous inotropic therapy. J Heart Lung Transplant. 2001;20:449-456.
14. Cimato TR, Jessup M. Recipient selection in cardiac transplantation: contraindications and risk factors for mortality. J Heart Lung Transplant. 2002;21:1161-1173.
15. De Feo P, Lucidi P. Liver protein synthesis in physiology and in disease states. Curr Opin Clin Nutr Metab Care. 2002;5:47-50.
16. Goldwasser P, Feldman J. Association of serum albumin and mortality risk. J Clin Epidemiol. 1997;50:693-703.
17. Menon V, Greene T, Wang X, Pereira AA, Marcovina SM, Beck GJ, Kusek JW, Collins AJ, Levey AS, Sarnak MJ. C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney Int. 2005;68:766-772.
18. Read JA, Choy ST, Beale PJ, Clarke SJ. Evaluation of nutritional and inflammatory status of advanced colorectal cancer patients and its correlation with survival. Nutr Cancer. 2006;55:78-85.
19. Allen LA, Felker GM, Pocock S, McMurray JJ, Pfeffer MA, Swedberg K, Wang D, Yusuf S, Michelson EL, Granger CB; CHARM Investigators. Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. Eur J Heart Fail. 2009;11:170-177.
20. Uthamalingam S, Kandala J, Daley M, Patvardhan E, Capodilupo R, Moore SA, Januzzi JL Jr. Serum albumin and mortality in acutely decompensated heart failure. Am Heart J. 2010;160:1149-1155.
21. Yanagisawa S, Miki K, Yasuda N, Hirai T, Suzuki N, Tanaka T. Clinical outcomes and prognostic factor for acute heart failure in nonagenarians: impact of hypoalbuminemia on mortality. Int J Cardiol. 2010;145:574-576.
22. Dimaria-Ghalili RA. Nutrition risk factors in older coronary artery bypass graft patients. Nutr Clin Pract. 2008;23:494-500.
23. Blair JE, Zannad F, Konstam MA, Cook T, Traver B, Burnett JC Jr, Grinfeld L, Krasa H, Maggioni AP, Orlandi C, Swedberg K, Udelson JE, Zimmer C, Gheorghiade M; EVEREST Investigators. Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening heart failure results from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) program. J Am Coll Cardiol. 2008;52:1640-1648.
24. Gheorghiade M, Abraham WT, Albert NM, Gattis Stough W, Greenberg BH, O'Connor CM, She L, Yancy CW, Young J, Fonarow GC; OPTIMIZE-HF Investigators and Coordinators. Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry. Eur Heart J. 2007;28:980-8.
25. Vrtovec B, Radovancevic R, Delgado RM, Radovancevic B, Bracey AW, Gregoric ID, Frazier OH. Significance of anaemia in patients with advanced heart failure receiving long-term mechanical circulatory support. Eur J Heart Fail. 2009;11:1000-1004.
26. Zhang WJ, Frei B. Albumin selectively inhibits TNF alpha-induced expression of vascular cell adhesion molecule-1 in human aortic endothelial cells. Cardiovasc Res. 2002;55:820-829.
27. Sun HY, Singh N, Cacciarelli TV, Wannstedt C, Wagener MM, Steele C. Dysregulated expression of T-helper cell responses and susceptibility to infections in high-risk liver transplant recipients. Transpl Immunol. 2008;20:68-72.
28. Potapov EV, Wagner FD, Loebe M, Ivanitskaia EA, Müller C, Sodian R, Jonitz B, Hetzer R. Elevated donor cardiac troponin T and procalcitonin indicate two independent mechanisms of early graft failure after heart transplantation. Int J Cardiol. 2003;92:163-167.
29. Raichlin E, Bae JH, Kushwaha SS, Lennon RJ, Prasad A, Rihal CS, Lerman A. Inflammatory burden of cardiac allograft coronary atherosclerotic plaque is associated with early recurrent cellular rejection and predicts a higher risk of vasculopathy progression. J Am Coll Cardiol. 2009;53:1279-1286.
30. Otranto M, Souza-Netto I, Aguila MB, Monte-Alto-Costa A. Male and female rats with severe protein restriction present delayed wound healing. Appl Physiol Nutr Metab. 2009;34:1023-1031.
31. Lietz K, Long JW, Kfoury AG, Slaughter MS, Silver MA, Milano CA, Rogers JG, Naka Y, Mancini D, Miller LW. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation. 2007;116:497-505.
32. Matthews JC, Koelling TM, Pagani FD, Aaronson KD. The right ventricular failure risk score a pre-operative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates. J Am Coll Cardiol. 2008;51:2163-2172.